Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy - PubMed (original) (raw)
Review
. 2008 Mar 1;60(4-5):537-47.
doi: 10.1016/j.addr.2007.09.005. Epub 2007 Oct 25.
Affiliations
- PMID: 18037526
- DOI: 10.1016/j.addr.2007.09.005
Review
Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
Sébastien Deshayes et al. Adv Drug Deliv Rev. 2008.
Abstract
The recent discovery of new potent therapeutic molecules which do not reach the clinic due to poor delivery and low bioavailability have made of delivery a key stone in therapeutic development. Several technologies have been designed to improve cellular uptake of therapeutic molecules, including cell-penetrating peptides (CPPs), which have been successfully applied for in vivo delivery of biomolecules and constitute very promising tools. Distinct families of CPPs have been described; some require chemical linkage between the drug and the carrier for cellular drug internalization while others like Pep-and MPG-families, form stable complexes with drugs depending on their chemical nature. Pep and MPG are short amphipathic peptides, which form stable nanoparticles with proteins and nucleic acids respectively. MPG and Pep based nanoparticles enter cells independently of the endosomal pathway and efficiently deliver cargoes in a fully biologically active form into a large variety of cell lines as well as in animal models. This review will focus on the mechanisms of non-covalent MPG and Pep-1 strategies and their applications in cultured cells and animal models.
Similar articles
- A non-covalent peptide-based strategy for siRNA delivery.
Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G. Crombez L, et al. Biochem Soc Trans. 2007 Feb;35(Pt 1):44-6. doi: 10.1042/BST0350044. Biochem Soc Trans. 2007. PMID: 17233597 Review. - A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L, Morris MC, Heitz F, Divita G. Crombez L, et al. Methods Mol Biol. 2011;764:59-73. doi: 10.1007/978-1-61779-188-8_4. Methods Mol Biol. 2011. PMID: 21748633 - Cell-penetrating peptides: from molecular mechanisms to therapeutics.
Morris MC, Deshayes S, Heitz F, Divita G. Morris MC, et al. Biol Cell. 2008 Apr;100(4):201-17. doi: 10.1042/BC20070116. Biol Cell. 2008. PMID: 18341479 Review. - Recent advances in the use of cell-penetrating peptides for medical and biological applications.
Fonseca SB, Pereira MP, Kelley SO. Fonseca SB, et al. Adv Drug Deliv Rev. 2009 Sep 30;61(11):953-64. doi: 10.1016/j.addr.2009.06.001. Epub 2009 Jun 16. Adv Drug Deliv Rev. 2009. PMID: 19538995 Review. - Peptide-based nanoparticle for ex vivo and in vivo drug delivery.
Crombez L, Morris MC, Deshayes S, Heitz F, Divita G. Crombez L, et al. Curr Pharm Des. 2008;14(34):3656-65. doi: 10.2174/138161208786898842. Curr Pharm Des. 2008. PMID: 19075741
Cited by
- Protein Transduction Domain Mimic (PTDM) Self-Assembly?
D Posey N, N Tew G. D Posey N, et al. Polymers (Basel). 2018 Sep 19;10(9):1039. doi: 10.3390/polym10091039. Polymers (Basel). 2018. PMID: 30960964 Free PMC article. - Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
Zhang C, Ren W, Liu Q, Tan Z, Li J, Tong C. Zhang C, et al. Drug Des Devel Ther. 2019 Apr 4;13:1059-1068. doi: 10.2147/DDDT.S195481. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31040643 Free PMC article. - A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells.
Borghouts C, Delis N, Brill B, Weiss A, Mack L, Lucks P, Groner B. Borghouts C, et al. JAKSTAT. 2012 Jan 1;1(1):44-54. doi: 10.4161/jkst.18947. JAKSTAT. 2012. PMID: 24058750 Free PMC article. - Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo.
Andaloussi SE, Lehto T, Mäger I, Rosenthal-Aizman K, Oprea II, Simonson OE, Sork H, Ezzat K, Copolovici DM, Kurrikoff K, Viola JR, Zaghloul EM, Sillard R, Johansson HJ, Said Hassane F, Guterstam P, Suhorutšenko J, Moreno PM, Oskolkov N, Hälldin J, Tedebark U, Metspalu A, Lebleu B, Lehtiö J, Smith CI, Langel U. Andaloussi SE, et al. Nucleic Acids Res. 2011 May;39(9):3972-87. doi: 10.1093/nar/gkq1299. Epub 2011 Jan 17. Nucleic Acids Res. 2011. PMID: 21245043 Free PMC article. - Tumor-targeted RNA-interference: functional non-viral nanovectors.
Pan X, Thompson R, Meng X, Wu D, Xu L. Pan X, et al. Am J Cancer Res. 2011 Sep 1;1(1):25-42. Am J Cancer Res. 2011. PMID: 21572539 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous